Sunday, April 7, 2013

ADT in High-Risk Prostate Cancer: How to Advise Patients?

Dr. Gerald Chodak interprets findings from a new study comparing 18-month vs 36-month hormone therapy in high-risk prostate cancer ...more

No comments:

Post a Comment

Popular Posts